RT Journal Article
SR Electronic
T1 SARS-CoV-2 epidemic in the South American Southern cone: can combined immunity from vaccination and infection prevent the spread of Gamma and Lambda variants while easing restrictions?
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.09.16.21263701
DO 10.1101/2021.09.16.21263701
A1 Marcelo Fiori
A1 Gonzalo Bello
A1 Nicolás Wschebor
A1 Federico Lecumberry
A1 Andrés Ferragut
A1 Ernesto Mordecki
YR 2021
UL http://medrxiv.org/content/early/2021/09/21/2021.09.16.21263701.abstract
AB All South American countries from the Southern cone (Argentina, Brazil, Chile, Paraguay and Uruguay) experienced severe COVID-19 epidemic waves during early 2021 driven by the expansion of variants Gamma and Lambda, however, there was an improvement in different epidemic indicators since June 2021. To investigate the impact of national vaccination programs and natural infection on viral transmission in those South American countries, we analyzed the coupling between population mobility and the viral effective reproduction number Rt. Our analyses reveal that population mobility was highly correlated with viral Rt from January to May 2021 in all countries analyzed; but a clear decoupling occurred since May-June 2021, when the rate of viral spread started to be lower than expected from the levels of social interactions. These findings support that populations from the South American Southern cone probably achieved the conditional herd immunity threshold to contain the spread of regional SARS-CoV-2 variants.Competing Interest StatementThe authors have declared no competing interest.Funding StatementUniversidad de la Republica, Uruguay. Instituto Oswaldo Cruz (FIOCRUZ), Brazil. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No approval required.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll the data and code used in this paper are publicly available, and linked along the text. https://github.com/marfiori/covid19-decoupling